{"nct_id":"NCT01108705","title":"Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment","status":"TERMINATED","status_verified_date":"2015-09","start_date":"2010-05","start_date_type":null,"primary_completion_date":"2013-10","primary_completion_date_type":"ACTUAL","completion_date":"2013-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}